[Relapse mechanism and coping strategies of CD19 chimeric antigen receptor T cells in the treatment of diffuse large B-cell lymphoma]

Zhonghua Xue Ye Xue Za Zhi. 2022 Sep 14;43(9):788-792. doi: 10.3760/cma.j.issn.0253-2727.2022.09.014.

[Article in Chinese]

Authors

Q Zhang¹, Y Xiao¹

Affiliation

¹ Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.

PMID: 36709176
PMCID: PMC9613498
DOI: 10.3760/cma.j.issn.0253-2727.2022.09.014

No abstract available

MeSH terms

Adaptation, Psychological
Antigens, CD19
Humans
Immunotherapy, Adoptive
Lymphoma, Large B-Cell, Diffuse* / pathology
Lymphoma, Large B-Cell, Diffuse* / therapy
Neoplasm Recurrence, Local
Receptors, Antigen, T-Cell
Receptors, Chimeric Antigen*
T-Lymphocytes / pathology

Substances

Receptors, Chimeric Antigen
Receptors, Antigen, T-Cell
Antigens, CD19